Application of starch, cellulose, and their derivatives in the development of microparticle drug-delivery systems

P Lukova, P Katsarov, B Pilicheva - Polymers, 2023 - mdpi.com
Micro-and nanotechnologies have been intensively studied in recent years as novel
platforms for targeting and controlling the delivery of various pharmaceutical substances …

Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases

E Kole, K Jadhav, N Shirsath, P Dudhe… - Journal of Drug Delivery …, 2023 - Elsevier
Pulmonary diseases pose an immense threat to global health. Several nanotherapeutics-
based approaches aimed to tackle pulmonary ailments in recent years. The current …

Clofazimine nanoclusters show high efficacy in experimental TB with amelioration in paradoxical lung inflammation

K Jadhav, A Jhilta, R Singh, E Ray, N Sharma… - Biomaterials …, 2023 - Elsevier
The rise of tuberculosis (TB) superbugs has impeded efforts to control this infectious ailment,
and new treatment options are few. Paradoxical Inflammation (PI) is another major problem …

Trans-nasal brain delivery of anti-TB drugs by methyl-β-cyclodextrin microparticles show efficient mycobacterial clearance from central nervous system

K Jadhav, A Jhilta, R Singh, S Sharma, S Negi… - Journal of Controlled …, 2025 - Elsevier
Central nervous system tuberculosis (CNS-TB) is the most severe extra-pulmonary
manifestation of tuberculosis (TB), facing significant challenges due to the limited …

Effective cerebral tuberculosis treatment via nose-to-brain transport of anti-TB drugs using mucoadhesive nano-aggregates

K Jadhav, A Jhilta, R Singh, E Ray, V Kumar, AB Yadav… - Nanoscale, 2024 - pubs.rsc.org
Central nervous system tuberculosis (CNS-TB) is a severe form of extra-pulmonary
tuberculosis with high mortality and morbidity rates. The standard treatment regimen for CNS …

Fat fighting liraglutide based nano-formulation to reverse obesity: design, development and animal trials

DK Jakhar, VK Vishwakarma, R Singh, K Jadhav… - International Journal of …, 2023 - Elsevier
Obesity is a metabolic disease, which is one of the major causes of morbidity and mortality,
where therapeutic options are limited. Treatment of obesity is necessary as it is associated …

Engineered vildagliptin-loaded polymeric nanoparticles via microfluidic and spray drying for enhanced antidiabetic activity

E Kole, K Jadhav, Z Khan, RK Verma… - Future Journal of …, 2024 - Springer
Background Vildagliptin (VLG), an antidiabetic agent, presents a potential solution to this
widespread affliction. It exhibits notable attributes, such as a high solubility and a shorter …

Nano-based carriers for pulmonary drug delivery: A review on the available drug delivery applications and toxicity issues

PI Siafaka, EÖ Bülbül, AN Miliotou, ID Karantas… - Journal of Drug Delivery …, 2024 - Elsevier
In the last decade, nanocarriers have been widely used to target specific organs and
disorders of any kind. Nonetheless, the commercialization of nanocarriers for many …

Targeted delivery of the metastasis-specific tumour homing TMTP1 peptide to non-small-cell lung cancer (NSCLC) using inhalable hybrid nano-assemblies

E Ray, K Jadhav, M Kadian, G Sharma… - Journal of Materials …, 2024 - pubs.rsc.org
Lung cancer is one of the most fatal malignancies, with the highest death rate (∼ 19%), and
the NSCLC type accounts for∼ 85% of lung cancers. In the search for new treatments …

Inhalable chitosan-coated nano-assemblies potentiate niclosamide for targeted abrogation of non-small-cell lung cancer through dual modulation of autophagy and …

E Ray, K Jadhav, M Kadian, G Sharma… - International Journal of …, 2024 - Elsevier
Lung carcinoma, particularly non-small-cell lung cancer (NSCLC), accounts for a significant
portion of cancer-related deaths, with a fatality rate of approximately 19%. Niclosamide …